The state of Michigan, known for its diverse healthcare ecosystem, is currently at a critical juncture in its regulatory evolution. Healthcare businesses, from innovative telehealth platforms to burgeoning medspa enterprises and traditional practices, are facing an increasingly scrutinized environment. The Michigan Board of Medicine, along with other state agencies, is actively monitoring and enforcing regulations, signaling a clear message: robust compliance is no longer optional, but foundational for sustainable operation.
For more on this topic, see our analysis: Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.
This comprehensive guide will dissect Michigan's unique regulatory framework, offering actionable insights for any healthcare entity considering or currently operating within the state. We'll cover everything from the nuances of its Corporate Practice of Medicine doctrine to specific telehealth requirements and the Board's recent enforcement trends.
For more on this topic, see our analysis: Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.
Michigan's Corporate Practice of Medicine (CPOM): A Nuanced Approach
Michigan's stance on the Corporate Practice of Medicine (CPOM) is less restrictive than some of its more stringent counterparts like Iowa or Kentucky, yet it still demands careful consideration. While Michigan does not have an explicit, overarching statute prohibiting the corporate employment of physicians, the underlying principles of CPOM are embedded within various professional practice acts and administrative rules. The primary concern is preventing unlicensed individuals or entities from controlling medical decision-making or interfering with the physician-patient relationship.
For telehealth brands and medspas, this means that while a non-physician-owned entity might employ physicians or other licensed professionals, the clinical autonomy of those professionals must be unequivocally preserved. The entity cannot dictate medical judgments, influence treatment protocols based on financial incentives, or engage in fee-splitting arrangements that violate professional ethics or anti-kickback statutes. Management Service Organization (MSO) models are widely utilized, but they must be structured meticulously. The MSO should provide only administrative, non-clinical services (e.g., billing, marketing, IT, facilities management) to a professional entity, which retains full control over clinical decisions, hiring/firing of clinical staff, and professional fee collection. Any MSO agreement must clearly delineate these boundaries and ensure fair market value compensation for services rendered, independent of patient volume or revenue from medical services.
Dental practices and chiropractic offices generally have more specific statutory allowances for corporate structures within their respective practice acts. However, any expansion into adjunctive medical services or novel business models must still respect the overarching principle that clinical decisions remain solely with the licensed practitioner.
Key Takeaway: While Michigan permits corporate employment of physicians, the spirit of CPOM requires that clinical independence and the integrity of the physician-patient relationship remain paramount. Structure your MSO and employment agreements with precision, ensuring clear separation of clinical and administrative control.
Telehealth in Michigan: Evolving Regulations and Provider Requirements
Michigan has embraced telehealth, particularly accelerated by the COVID-19 Public Health Emergency (PHE). However, the state has also moved to solidify its regulatory framework, ensuring quality and patient safety. The Michigan Public Health Code (MCL 333.16284) and administrative rules govern telehealth practice.
Establishing a Valid Provider-Patient Relationship
Crucially, Michigan allows for the establishment of a provider-patient relationship via telehealth, provided it is through real-time interactive audio-visual technology. This means that for initial consultations and ongoing care where a new relationship is being formed, asynchronous modalities or audio-only calls are generally insufficient. This aligns with many states, including the District of Columbia, which prioritize a robust initial encounter.
For telehealth brands, this dictates the technological capabilities required and the clinical protocols for onboarding new patients. Platforms must support secure, high-quality video conferencing. Providers must be licensed in Michigan and adhere to the same standard of care as in-person visits.
Medical Board Requirements for Telehealth Providers
The Michigan Board of Medicine (and other professional boards) expects telehealth providers to:
- Be licensed in Michigan: This is non-negotiable. Providers must hold an active, unrestricted Michigan license to treat patients located in the state.
- Adhere to the standard of care: Telehealth services must meet the same standard of care as in-person services. This includes proper documentation, diagnosis, treatment planning, and follow-up.
- Ensure patient identification and consent: Robust processes for verifying patient identity and obtaining informed consent for telehealth services are mandatory.
- Maintain patient privacy and security: HIPAA compliance is a baseline, requiring secure, encrypted platforms and strict data handling protocols.
Recent Enforcement Trends: The Michigan Board of Medicine has shown increased vigilance, particularly regarding unprofessional conduct, scope of practice violations, and inadequate supervision within telehealth. This means ensuring that practitioners are operating strictly within their licensed scope and that any delegated tasks are appropriately supervised.
Controlled Substance Prescribing via Telehealth
This is perhaps the most complex and rapidly evolving area of telehealth regulation, heavily influenced by federal DEA rules and state-specific laws. Michigan's Public Health Code (MCL 333.7333) governs controlled substance prescribing. While Michigan generally aligns with federal guidelines, the expiration of federal COVID-19 PHE waivers has brought renewed scrutiny.
Federal and State Interplay
The DEA's proposed rules, while still under review, indicate a strong lean towards requiring an initial in-person medical evaluation for Schedule II and certain Schedule III-V controlled substances prescribed via telehealth. While temporary extensions for PHE-established relationships are in place until November 2024, the long-term trend is towards stricter requirements. Buprenorphine for Opioid Use Disorder (OUD) has specific considerations, often allowing for initial telehealth prescribing under certain conditions, but even here, the DEA is seeking to balance access with diversion prevention.
For telehealth brands prescribing controlled substances in Michigan, this means:
- Strict adherence to DEA regulations: Providers must hold a valid DEA registration in Michigan. The Ryan Haight Act's in-person exam requirement is effectively back in play, with limited exceptions.
- Michigan-specific rules: Ensure compliance with Michigan's Public Health Code regarding prescription monitoring programs (MAPS), quantity limits, and refill restrictions.
- Robust documentation: Every controlled substance prescription must be supported by thorough documentation demonstrating a legitimate medical purpose after a comprehensive evaluation.
Compliance Pitfall: Relying solely on federal PHE waivers without understanding the underlying state and pre-PHE federal requirements is a significant risk. The DOJ's intensified enforcement against telehealth controlled substance prescribing violations underscores the critical need for absolute adherence to legitimate medical purpose standards.
Medspas: Scope of Practice and Supervision Requirements
Michigan's medspa industry is booming, but it operates under strict regulations governing the scope of practice for various licensed professionals and the requirements for supervision. The Michigan Board of Medicine is particularly focused on ensuring that medical procedures are performed by appropriately licensed individuals under proper medical direction.
Scope of Practice
- Physicians (MD/DO): Can perform all medical procedures within their scope.
- Physician Assistants (PAs) and Nurse Practitioners (NPs): Can perform many procedures under the supervision or delegation of a physician, but their scope is defined by their license and collaborative agreements. For instance, an NP's scope is defined by their specialty certification and the Michigan Public Health Code (MCL 333.17210).
- Registered Nurses (RNs): Can perform delegated medical tasks under direct supervision, but cannot independently diagnose or prescribe.
- Estheticians: Can perform non-medical aesthetic services. Any service crossing into medical territory (e.g., injectables, certain laser treatments, deep chemical peels) is outside their scope.
Supervision Requirements
Michigan generally requires active and engaged medical direction for medspas. A medical director cannot be a mere figurehead. They must:
- Be a Michigan-licensed physician.
- Be actively involved in the medspa's operations, including developing protocols, training staff, and overseeing patient care.
- Provide appropriate levels of supervision based on the procedure and the delegating professional. For instance, certain procedures might require direct, on-site supervision, while others may allow for indirect supervision.
Compliance Pitfall: Misrepresenting services, allowing unlicensed personnel to perform medical procedures, or having a
Further Reading
- Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State
- The Looming Convergence: How Telehealth and Brick-and-Mortar Care Are Merging, and What It Means for Your Strategy
- The GLP-1 Gold Rush: Navigating the Regulatory Minefield in Telehealth Weight Loss
- The Intersecting Future: How Telehealth and Brick-and-Mortar Care Models Are Converging
